Skip to main content
logo
Vistagen Therapeutics, Inc. (VTGN)
NASDAQ: VTGN · Real-Time Price · USD
0.1683
-0.0024 (-1.41%)
At close: Oct 30, 2026, 4:00 PM EDT
0.1695
+0.0012 (0.71%)
After-hours: Oct 30, 2026, 7:56 PM EDT

Vistagen Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Apr - Mar.

Operating Activities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Net Income
-67.62-69.69-51.42-29.36-59.25-47.76
Depreciation & Amortization
0.760.730.640.570.530.71
Other Amortization
-----0.23
Loss (Gain) From Sale of Assets
---0.01--
Loss (Gain) From Sale of Investments
-0.55-0.54-0.39---
Stock-Based Compensation
4.0744.322.183.343.48
Other Operating Activities
-0---3.64-
Change in Accounts Payable
3.20.835.680.52-0.931.69
Change in Unearned Revenue
-2.43-1.2-0.410.520.21-1
Change in Other Net Operating Assets
0.27-0.57-0.51-0.252.76-2.6
Operating Cash Flow
-62.3-66.44-42.1-25.81-49.72-45.26
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Capital Expenditures
-0.09-0.15-0.19-0.06-0.21-0.2
Cash Acquisitions
-----0.53-
Investment in Securities
-0-0.73-12.96---
Investing Cash Flow
-0.09-0.88-13.15-0.06-0.74-0.2

Financing Activities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Short-Term Debt Issued
-1.02----
Total Debt Issued
-1.02----
Short-Term Debt Repaid
--0.93--0.99-1.03-
Long-Term Debt Repaid
------0
Total Debt Repaid
-0.93-0.93--0.99-1.03-0
Net Debt Issued (Repaid)
-0.930.1--0.99-1.03-0
Issuance of Common Stock
31.3230.883.21129.390.1710.49
Other Financing Activities
-----0.17-
Financing Cash Flow
30.3930.973.21128.4-1.0410.48

Net Cash Flow

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Net Cash Flow
-31.99-36.34-52.04102.53-51.5-34.97

Free Cash Flow

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Free Cash Flow
-62.38-66.59-42.29-25.87-49.93-45.46
Free Cash Flow Growth
------
Free Cash Flow Margin
-2494.32%-5247.20%-8701.24%-2431.77%--4099.28%
Free Cash Flow Per Share
-1.53-1.75-1.37-1.34-7.17-6.89
Levered Free Cash Flow
-36.95-40.5-22.83-18-32.74-25.98
Unlevered Free Cash Flow
-36.95-40.5-22.83-18-32.74-26.21

Additional Metrics

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash Interest Paid
0.030.03----
Change in Working Capital
1.04-0.944.760.792.03-1.92
SEC Filings: 10-K · 10-Q